Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)

  • End date
    Apr 1, 2023
  • participants needed
  • sponsor
    CanSino Biologics Inc.
Updated on 12 August 2021
conjugate vaccine
pneumococcal vaccine


Streptococcus pneumoniae is a major cause of morbidity and mortality in children worldwide, resulting in up to 1 million pediatric deaths every year.Since the licensure of PCV7 and PCV13,the reported overall decline in invasive pneumococcal disease in hospitalized children younger than 5 years several years is approximately 60% in Western countries.This is a single center,blind, randomized, positive-controlled clinical trial.The purpose of this study is to preliminary evaluate the safety of PCV13i vaccine in subjects at age of 7 months and above,and to investigate the safety and immunogenicity of PCV13i vaccine at age of 2 and 3 months,compared to PCV13.

Condition streptococcus pneumoniae infections, Bacterial Infections, Strep Throat, streptococcal infections, pneumococcal infections, Pneumococcal infection, bacterial disease, Bacterial Infection, Streptococcal infection, Pneumococcal Disease, strep
Treatment 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(CRM197,TT), 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Clinical Study IdentifierNCT04841369
SponsorCanSino Biologics Inc.
Last Modified on12 August 2021


Yes No Not Sure

Inclusion Criteria

Healthy subjects of 2 months (minimum 6 weeks), 3 months , 7 months and above
Willing to provide proof of identity
Without vaccination history of pneumococcal vaccine
None-pregnancy or do not plan to pregnancy recently
Volunteers of 18 years old and above who have the ability to understand clinical studie progress and sign informed consent
Volunteers of 8-17 years old and their guardians who willing sign informed consent
Able to understand and sign the informed consent by their guardians or trustees for the volunteers of 8 years old and below
Able and willing comply with the requirements of the protocol

Exclusion Criteria

Volunteers whose axillary body temperature was >37.0# before vaccination
Volunteers who suffered from Congenital malformation or developmental disorder, genetic defect, severe malnutrition, etc
Volunteers who has a history of epilepsy, convulsions or psychosis
Allergic person
Any prior administration of blood products in last 3 month
Any prior administration of other research medicines in last 1 month
Plans to participate in or is participating in any other drug clinical study
Any prior administration of attenuated live vaccine in last 14 days
Any prior administration of subunit or inactivated vaccines in last 7 days
Had fever before vaccination, Volunteers with temperature >37.0C on axillary setting
According to the investigator's judgement, the subjects have any other factors that make them unfit to enroll the clinical trial
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note